Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP-MSU: Tranexamic Acid for Hyperacute ICH
NCT03385928Phase 2Completed
- Sponsor
- Neuroscience Trials Australia
- Start
- Mar 2018
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of tranexamic acid in intracerebral hemorrhage (ICH), sponsored by Neuroscience Trials Australia. Started Mar 2018; status: completed.
02
Drugs
tranexamic acid
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT03385928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03385928.